Lilac Diesel or Purps: terpinolene versus caryophyllene and one untraceable lineage

• Profile. Lilac Diesel leads with terpinolene, Purps leads with caryophyllene.
• Availability. Both are supplied by S-LAB, Synoptis Pharma, Tilray, so one order can cover both.
• Origin. The lineage of one is established, the other is not, so we cannot compare them by origin.
• What this table does not say. It does not include the declared content as a single number or price. Which strain is suitable for whom is determined by the attending physician, not by the comparison of features.

What do these two strains really differ in?

In leading terpene and origin, not potency. Both sources place terpinolene at the forefront of the Lilac Diesel profile, and caryophyllene at the forefront of Purps. The lineage of the first strain has been publicly provided by the breeder, while the lineage of the second has not been established at all. The declared content of active substances is the same on both sides, so the number of this pair does not separate them.

Agreement on the profile leader is stronger here than is often the case in this comparison. For Lilac Diesel, the base providing weights places terpinolene well ahead of the next position, and the service listing only the order names it first. For Purps, both sources consistently indicate caryophyllene, followed closely by nerolidol. The dispute among sources only begins lower down, at the tail end of the list, and that constitutes the real content of this comparison.

The second difference lies in how consistently one and the other have been described. Six pharmacy entries for Lilac Diesel receive the same set of aroma descriptors in the database: citrus, floral, and lavender, plus a fuel component. Four entries for Purps receive three different sets, sharing exactly one word, earthy. This is not a difference between the plants, but between the quality of the description.

The genetic class is even disputed for both names. For the first strain, sources write once about a hybrid, once about a sativa strain, while for the second, they waver between a hybrid with indica dominance and a pure indica. Those looking for a separation of this pair in percentages or genetic labeling will find none here or there.

What connects them?

Almost the entire set of names in the profile and the path to the pharmacy shelf. Of the nine terpenes mentioned with this pair, seven stand on both sides. There is also a common group of producers and a range of declarations. The lineage graph does not connect these strains in any way, as one of them has no recorded parents.

The common core of the profile is larger than the leading terpene label suggests. On both sides stand bisabolol, humulene, caryophyllene, limonene, linalool, myrcene, and pinene. Each strain has exactly one unique name: terpinolene for Lilac Diesel, nerolidol for Purps. Thus, the entire difference in composition boils down to two positions on the list and to weights that one of the sources does not provide at all.

They are also connected by the way they reach the Polish pharmacy. Both are listed in the registration positions of S-LAB, Synoptis Pharma, and Tilray, and industry publications state that the first two entities maintain trade relations with the third. For the patient, this means that the producer’s name on the packaging does not have to indicate a different cultivation, and each of these strains is described separately in its dedicated entry about Lilac Diesel and in the entry about Purps.

What does not connect them in any verifiable way is their origin. The parents of the first strain are recorded in the graph, while the parents of the second are not, so a common ancestor cannot be indicated or excluded. An empty field does not mean a negative answer here, and we treat it as a lack of knowledge, not as evidence of a lack of kinship.

Where does each of these strains come from?

One has a lineage documented by the breeder, the other comes from nowhere, with the latter being the result of verification, not a gap in our work. Lilac Diesel has four recorded parents and a stated author of the cross. For Purps, the verification ended with the determination that the origin of the pharmacy entry cannot be established.

On the side of Lilac Diesel, the record is short and verifiable. Seed banks attribute this strain to an American breeding company and indicate four parental lines. The first two are silver lemon haze and forbidden fruit, the next two are nyc cherry pie and citral glue. The name carries a fuel component, but none of the four parents have such a component, so the word in the name does not come from the lineage and says nothing about it.

On the side of Purps, the verification yielded the opposite result and is worth stating outright. The name circulates in at least three different lines: a clone strain from Mendocino County, for which the breeding base itself describes the second parent as unknown, its seed version released later by a Canadian company, and a separate purple family, for which the most frequently repeated cross is purple urkle with big bud. Polish descriptions of the same pharmacy entry sometimes refer to one version, sometimes to another, and no producer document mentions the parents.

Therefore, the lineage field here has an unknown value and is not a field to be filled in. Entering any of the circulating versions would create a false connection with strains that have documented lineages: in the same comparison stands Big Purple Dragon with a recorded parent purple urkle, and adopting the popular Polish version would make these two names close relatives without any basis.

How do the lists of terpenes provided by the two sources differ?

By a discrepancy that has a different direction on each side. For both strains, the sources differ in composition, but not in the same way: for Purps, one source simply provides a shorter version of the other’s list, while for Lilac Diesel, each of them lists something that the neighbor does not have at all.

For Purps, the direction is one-sided. The database describing four pharmacy entries lists a complete set of eight names, while the service describing one entry lists four, and all four fit within that complete set. The shorter version lacks humulene, linalool, myrcene, and pinene, while it does not add any unique names. It is therefore a subset of the longer one, which fits well with the fact that it is backed by one side instead of four.

For Lilac Diesel, both lists go beyond each other. The base with weights adds bisabolol, humulene, and limonene, which the other side does not mention, while the other side adds myrcene, which is absent in that taxonomy. Neither list contains the other, so it cannot be said that one is a shortened version of the other. The discrepancy is, in fact, within one service: on the pages of this strain, the list of names and the weight table contradict each other, while for Purps, both places provide the same on each page.

We do not provide percentage shares for the names, and this pair shows why better than any general argument. For the first strain, the complete set of numbers repeats in each of the six entries and sums to 58 percent. For the second, the same database provides a sum of 99 percent once, and 89 percent another time, and this is for entries of the same cultivar. The denominator is therefore unknown, and also unstable within one source.

What active substance levels do the pharmacy entries of both strains declare?

The same, and this number does not resolve anything here. The declared THC content encompasses the same range of 16.2-24.2% on both sides, as in both cases, the registered entries reaching the Polish shelf have two different nominal levels. Therefore, the range describes the assortment, not the plant.

These are not the ranges of one producer and do not result from the ten percent tolerance itself. The range arises from the declarations of several separate registered entries, some of which state a lower nominal level, while others state a higher one, and only each of them separately receives its own deviation from the declared value. One nominal number cannot yield the endpoints of 16.2-24.2%.

The distribution of levels on both sides is, however, different. Eight collected entries of Lilac Diesel are evenly divided, four for each level, while the base indicating availability marks as present in sales only those with the higher level. For Purps, the lower level is declared by one entry out of five collected, so the lower end of the range stands on a single registered entry, and its withdrawal would make the entire strain appear stronger, even though nothing has changed within it.

Availability also changes over time, as it is determined by individual batches and delivery dates, not by the description of the cultivar. What is on pharmacy shelves today is continuously updated in the list of available medical marijuana strains.

How long do both strains take to take effect and how long does the effect last?

Identically, as the speed depends on the method of administration, not the name on the package. Neither of them has been dedicated to a separate pharmacokinetic study, so no difference in the time of action can be demonstrated between this pair in either direction. The following description pertains to the method of administration itself and applies to both names.

The method of administration determines the course more than the strain itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect wears off within two to four hours. After ingestion, the substance first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode lasts six, sometimes eight hours. Hence the most common mistake with oral administration: those who think nothing is happening after thirty minutes and take another dose will receive both doses at once. The above ranges describe the method of administration, not this strain; no pharmacokinetic study for a single cultivar has been published.

What is known about the effects of both these strains, and what has not been demonstrated?

It is known separately about two terpenes, nothing about the strains themselves. Terpinolene has two preclinical studies, caryophyllene has two others, and none of these four pertained to the flower or the patient. Everything else circulating about the effects of this pair is patient reports or sales material.

On the side of Lilac Diesel, both studies are either animal or test tube studies. Inhaled terpinolene exhibited sedative effects in mice; the effect was also maintained in mice with impaired olfaction, indicating that the action occurred after the compound was absorbed into the body through the nose, not solely through the perception of smell. The second study pertains to a completely different question. Terpinolene lowered the level of AKT1 protein and inhibited the proliferation of human leukemia cells of the K562 line in culture; the study did not address pain, sleep, or anxiety.

No effect of terpinolene on pain, anxiety, or sleep has been demonstrated in humans or in any animal pain model; the available data only includes sedative effects after inhalation in mice and its impact on leukemia cell line in a test tube.

On the side of Purps, the material is different, as it includes the mechanism and pain model. (E)-caryophyllene selectively bound to the CB2 receptor (Ki = 155 nM) and inhibited carrageenan-induced paw swelling in wild-type mice, but not in CB2 receptor-deficient mice (Cnr2-/-), indicating a CB2-dependent mechanism; the study did not include any anxiety tests. The second study went further into pain. Oral caryophyllene reduced the late inflammatory phase of pain in the formalin test in a CB2 receptor-dependent manner, with no effect on the early phase; in a neuropathic pain model, it alleviated thermal hyperalgesia and mechanical allodynia without developing tolerance with chronic administration.

Neither of the two studies tested caryophyllene in humans or in inhaled form from the flower; both studies pertain to oral or systemic administration in mice in pain and inflammatory models, not sleep or mood.

Both boundaries must be read separately for each side of the pair. Stronger material on one side does not transfer to the other, and above all, none of these results indicate what the flower administered to the patient does, as in each of the four cases, a single compound was studied, not the plant.

What side effects have been reported for each of these two strains?

There are no reports attributed to either of these two names, as safety oversight is conducted by a registry according to the medicinal product series, and the cultivar does not appear in such a record. The symptoms described below pertain to the entire group of cannabis raw materials. A different number of reports for the two names would not be evidence of a difference in safety.

Reports of adverse effects are collected for the medicinal product with a serial number, not for the strain name, so the following pertains to cannabis flower as a group of raw materials. The most commonly reported symptoms are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for cannabis flower in Poland do not separate them by individual products.

The only thing that can be said separately about this pair comes from sales material: one of the strains is attributed stimulating effects, the other relaxing. This is a sales label, not a clinical observation, and does not say anything about which of them more frequently exhibits the symptoms mentioned above. Anyone who notices any of them should report it to their attending physician, as only they see the entire list of preparations being taken.

Frequently asked questions about Lilac Diesel and Purps

Which of these two strains has stronger flower?

The declarations on both sides encompass the same range of active substance content, so based on the number from the registry, it is not possible to indicate which is stronger. The difference between two individual pharmacy entries of the same strain can be greater than the difference between these two names.

Are Lilac Diesel and Purps related?

It is unknown and cannot be determined. The parents of Lilac Diesel are recorded in the lineage graph, while the parents of Purps are not, so a common ancestor cannot be indicated or excluded.

Why do you not provide lineage for Purps?

Because the name circulates in several different breeding lines, and none of them can be confidently assigned to the entry sold in Polish pharmacies. Entering any of the circulating versions would create a false kinship with strains that have documented lineages.

If both strains have almost the same set of terpenes, why separate them?

Because a set of names is not the same as a profile. Both sources consistently place terpinolene at the forefront of the first strain and caryophyllene at the forefront of the second, and this difference is not shown by the list of components alone.

Are the percentage shares of terpenes provided online reliable?

Not enough to quote them. For the first of these strains, the numbers provided by the Polish database sum to 58 percent, for the second once to 99, and once to 89 percent, so the denominator is unknown and variable even within one source.

Is cannabis flower sold without a prescription the same product?

No, it is a different shelf: at the address of the flower category is hemp flower with cannabidiol, sold without a prescription and with a content of psychoactive substances below the legal threshold, while both strains described here are pharmaceutical raw materials issued only by a doctor’s prescription.

Cannabis flower is a pharmaceutical raw material issued by a doctor’s prescription in the Rpw category. The material is informational in nature and does not replace medical advice. The editorial text was prepared by the editorial team of ubucha.pl.